Press Announcements > Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to strengthen the agency’s process for issuing public warnings and notifications of recalls

Press Announcements > Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to strengthen the agency’s process for issuing public warnings and notifications of recalls

Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to strengthen the agency’s process for issuing public warnings and notifications of recalls

The U.S. Food and Drug Administration is taking new steps to strengthen and modernize the process for issuing a public warning about a voluntary recall and for notification of recalls.  Most companies collaborate with the FDA to rapidly initiate voluntary recalls and work with their supply chain partners to remove the product from shelves to prevent further distribution. And in general, a recall occurs quickly when the problem is discovered. However, there are situations where the FDA may need to provide safety advice to marketplace to protect consumers.